31 of 102 participants ( 30 % ) in the `` TB '' group , 11 of 56 ( 20 % ) in the `` other disease '' group , and 287 of 1413 ( 20 % ) in the `` no disease '' group experienced a primary outcome event ( p = 0.042 ) .